Neoadjuvant Chemotherapy With Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results After a Median Follow-Up of Over 4 Years
Breast Care - Switzerland
doi 10.1159/000452079
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
S. Karger AG